Investors love biotech stocks for the lottery ticket-like returns they can offer if a company strikes medical gold. Case in point: Ampliphi Biosciences …
Friday turned out to be a nightmare for shareholders of Ampliphi Biosciences Corp (NYSEMKT:APHB) after the biotechnology firm announced the pricing of an underwritten …
